Northern Trust Corp Foghorn Therapeutics Inc. Transaction History

Northern Trust Corp

  • $761 Billion
  • Q3 2025

A detailed history of Northern Trust Corp transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 284,301 shares of FHTX stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
284,301
Previous 286,700 0.84%
Holding current value
$1.33 Million
Previous $1.35 Million 3.19%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$4.58 - $6.5 $10,987 - $15,593
-2,399 Reduced 0.84%
284,301 $1.39 Million
Q2 2025

Aug 13, 2025
BUY
$3.15 - $4.9 $124,094 - $193,035
39,395 Added 15.93%
286,700 $1.35 Million
Q1 2025

May 13, 2025
SELL
$3.52 - $6.16 $22,408 - $39,214
-6,366 Reduced 2.51%
247,305 $902,000
Q4 2024

Feb 14, 2025
BUY
$4.61 - $9.35 $13,244 - $26,862
2,873 Added 1.15%
253,671 $1.2 Million
Q3 2024

Nov 13, 2024
BUY
$4.8 - $9.99 $287,265 - $597,871
59,847 Added 31.34%
250,798 $2.33 Million
Q2 2024

Aug 14, 2024
SELL
$5.05 - $8.0 $21,669 - $34,328
-4,291 Reduced 2.2%
190,951 $1.1 Million
Q1 2024

May 14, 2024
SELL
$2.82 - $7.94 $11,370 - $32,014
-4,032 Reduced 2.02%
195,242 $1.31 Million
Q4 2023

Feb 13, 2024
SELL
$2.94 - $6.76 $5,988 - $13,770
-2,037 Reduced 1.01%
199,274 $1.29 Million
Q3 2023

Nov 13, 2023
SELL
$5.0 - $9.87 $4,270 - $8,428
-854 Reduced 0.42%
201,311 $1.01 Million
Q2 2023

Aug 11, 2023
BUY
$5.37 - $8.84 $86,403 - $142,235
16,090 Added 8.65%
202,165 $1.42 Million
Q1 2023

May 15, 2023
BUY
$4.66 - $8.99 $21,724 - $41,911
4,662 Added 2.57%
186,075 $1.15 Million
Q4 2022

Feb 13, 2023
SELL
$5.44 - $9.46 $14,883 - $25,882
-2,736 Reduced 1.49%
181,413 $1.16 Million
Q3 2022

Nov 14, 2022
SELL
$7.52 - $18.01 $21,424 - $51,310
-2,849 Reduced 1.52%
184,149 $1.58 Million
Q2 2022

Aug 12, 2022
BUY
$8.48 - $16.84 $157,185 - $312,146
18,536 Added 11.0%
186,998 $2.54 Million
Q1 2022

May 13, 2022
SELL
$8.87 - $22.1 $17,864 - $44,509
-2,014 Reduced 1.18%
168,462 $2.57 Million
Q4 2021

Feb 08, 2022
SELL
$10.79 - $22.87 $49,590 - $105,110
-4,596 Reduced 2.63%
170,476 $3.9 Million
Q3 2021

Nov 15, 2021
BUY
$8.33 - $15.02 $101,392 - $182,823
12,172 Added 7.47%
175,072 $2.44 Million
Q2 2021

Aug 13, 2021
BUY
$9.32 - $13.26 $732,589 - $1.04 Million
78,604 Added 93.25%
162,900 $1.74 Million
Q1 2021

May 12, 2021
SELL
$11.8 - $23.11 $48,875 - $95,721
-4,142 Reduced 4.68%
84,296 $1.11 Million
Q4 2020

Feb 11, 2021
BUY
$15.12 - $25.88 $1.34 Million - $2.29 Million
88,438 New
88,438 $1.79 Million

Others Institutions Holding FHTX

# of Institutions
88
Shares Held
37M
Call Options Held
100
Put Options Held
0
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $195M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email